568-569 / 1816
Can systemic endocrine therapy remove the
need for clear margins?
•
Houssami meta-analysis showed
+ve margin had significant
negative effect even when
adjusted for anti-oestrogen use
and ER status.
•
The NSABP B14 Trial of
Tamoxifen versus placebo
demonstrated a 14 versus 4%
LRR